Literature DB >> 2430692

Enhanced expression of the N-myc gene in Wilms' tumors.

P D Nisen, K A Zimmerman, S V Cotter, F Gilbert, F W Alt.   

Abstract

Activation of myc-family oncogenes has been implicated in the genesis of a variety of neoplasms. In addition, these genes exhibit specific patterns of expression during murine development. We now report that N- and c-myc are differentially expressed in normal developing human renal tissues and in Wilms' tumor, a neoplasm which derives from primitive kidney cells. Twelve of 13 Wilms' tumors tested exhibited greatly enhanced levels of expression which occurred in the absence of gene amplification. We also detected N-myc expression in other primitive neoplasms including medulloblastoma and hepatoblastoma. Our observations suggest that N-myc expression is not limited to neuroectodermal tumors as was previously thought, but is a marker for several neoplasms that derive from primitive cell precursors. Finally, high level expression of N-myc was associated with markedly diminished levels of c-myc, suggesting that enhanced expression of N-myc gene might lead to down-regulation of c-myc.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430692

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

Review 1.  Diagnosis and classification of the small round-cell tumors of childhood.

Authors:  S L Cohn
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

2.  N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons.

Authors:  Kirmo Wartiovaara; Fanie Barnabe-Heider; Freda D Miller; David R Kaplan
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

3.  A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells.

Authors:  D A Haber; H T Timmers; J Pelletier; P A Sharp; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

4.  Regulation of N-myc gene expression: use of an adenovirus vector to demonstrate posttranscriptional control.

Authors:  L E Babiss; J M Friedman
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

5.  The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs.

Authors:  J De Greve; J Battey; J Fedorko; M Birrer; G Evan; F Kaye; E Sausville; J Minna
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

Review 6.  Oncogenes and urological malignancies: implications for the future.

Authors:  J A Schalken; A M van den Ouweland; F M Debruijne; H F Karthaus; W J Van de Ven
Journal:  Urol Res       Date:  1988

7.  N-myc oncogene amplification in a pediatric case of glioblastoma multiforme.

Authors:  A M Stenger; M L Garrè; A Cama; L Andreussi; M Brisigotti; G P Tonini; P Cornaglia-Ferraris
Journal:  Childs Nerv Syst       Date:  1991-11       Impact factor: 1.475

8.  Presence of the long chain form of polysialic acid of the neural cell adhesion molecule in Wilms' tumor. Identification of a cell adhesion molecule as an oncodevelopmental antigen and implications for tumor histogenesis.

Authors:  J Roth; C Zuber; P Wagner; I Blaha; D Bitter-Suermann; P U Heitz
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

9.  Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development.

Authors:  A J Buckler; J Pelletier; D A Haber; T Glaser; D E Housman
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

10.  A novel intron element operates posttranscriptionally To regulate human N-myc expression.

Authors:  L E Sivak; G Pont-Kingdon; K Le; G Mayr; K F Tai; B T Stevens; W L Carroll
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.